TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive President Asks $989.3 Million fr NCI, But Mistake In Grant Allocations May Lead To Additional Money February 4, 1983
TCL Archive FDA’s Handling Of UFT Raises Questions About Agency’s Isolation, Grasp Of Science. July 21, 2000
TCL Archive Kennedy Chooses Health/Education Chair Over Judiciary; No Major Changes In Senate Cancer Policies Expected November 14, 1986
